secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001213900-24-051625
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed to present at Emerging Growth Conference on June 13, 2024
---------------------------------------------------------------

- CEO Eric A. Adams will present a corporate overview at the Emerging Growth Conference 72.
- Presentation scheduled for 1:45pm EDT on June 13, 2024; registration link provided.
- Archived webcast available on EmergingGrowth.com, YouTube channel, or InMed IR page.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390024051625/0001213900-24-051625-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390024051625/ea0207653-8k_inmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-051625

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer